Physician profile
Alexis Pacis
NPI 1386112589
$728.78
in general payments reported to CMS, 2019-2025
20 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $463 · 2022: $19.66 · 2023: $95.02 · 2024: $34.66 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $95.02 | 2023 | Amyvid, Emgality, Reyvow |
| Genzyme Corporation | $71.55 | 2022-2025 | |
| Ucb, INC. | $65.87 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $55.37 | 2021 | |
| Janssen Pharmaceuticals, INC | $54.79 | 2021 | |
| Biogen, INC. | $45.14 | 2021 | |
| Eisai INC. | $38.40 | 2021 | |
| Sanofi-Aventis U.S. LLC | $38.28 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $35.07 | 2021 | |
| Ceribell, INC. | $34.66 | 2024 | Pocket Eeg Device |
| Ani Pharmaceuticals, INC. | $24.81 | 2025 | Purified Cortrophin Gel |
| Banner Life Sciences, LLC | $23.80 | 2021 | |
| Lundbeck LLC | $22.60 | 2025 | Vyepti |
| Biohaven Pharmaceuticals, INC. | $22.27 | 2021 | |
| Sk Life Science, INC. | $18.57 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $18.07 | 2021 | |
| Abbvie INC. | $17.13 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $17.06 | 2025 | Dysport |
| Kyowa Kirin, INC. | $15.53 | 2021 | |
| Boston Scientific Corporation | $14.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Pacis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.